HCSG HEALTHCARE SERVICES GROUP INC
Services-Nursing & Personal Care Facilities · Nasdaq · SEC CIK 731012 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.0%
TTM net income YoY163.9%
TTM EPS YoY174.1%
Revenue 3-yr CAGR4.0%
Net income 3-yr CAGR50.1%
Margins
Gross margin16.1%
Operating margin—
Net margin5.6%
FCF margin5.7%
EBITDA margin—
Returns
ROE20.4%
ROA12.7%
ROIC (approx.)—
Asset turnover2.27x
Leverage & solvency
Liabilities / assets37.5%
Debt / equity0.00x
Current ratio2.82x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.08x
Accruals ratio-1.0%
Payout ratio—
Capex / revenue0.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.84B | $1.72B |
| Cost of revenue | $1.60B | $1.49B |
| Gross profit | $239.41M | $228.09M |
| SG&A expense | $190.87M | $183.06M |
| Pretax income | $67.87M | $52.94M |
| Income tax | $8.81M | $13.47M |
| Net income | $59.06M | $39.47M |
| EPS (basic) | 0.82 | 0.54 |
| EPS (diluted) | 0.81 | 0.53 |
| Weighted avg. shares (diluted) | 73.03M | 73.99M |
| Balance sheet | ||
| Cash & equivalents | $125.19M | $60.13M |
| Short-term investments | $42.77M | $50.53M |
| Receivables | $281.30M | $330.91M |
| Inventory | $16.80M | — |
| Current assets | $576.41M | $556.65M |
| Goodwill | $79.80M | $75.53M |
| Intangibles | $6.96M | $9.44M |
| Total assets | $794.25M | $802.77M |
| Current liabilities | $170.38M | $192.55M |
| Total liabilities | $284.04M | $302.85M |
| Shareholders' equity | $510.21M | $499.93M |
| Shares outstanding | 69.60M | 73.20M |
| Cash flow statement | ||
| Operating cash flow | $144.97M | $30.80M |
| Capital expenditure | $5.82M | $6.34M |
| Free cash flow | $139.15M | $24.47M |
| Investing cash flow | -$11.00M | $6.05M |
| Financing cash flow | -$63.33M | -$31.05M |
| Depreciation & amortization | $16.78M | $14.59M |
| Stock-based compensation | $12.01M | $9.16M |
| Dividends paid | — | $0 |
| Share buybacks | $61.59M | $5.02M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.